PBE vs. THNR ETF Comparison

Comparison of PowerShares Dynamic Biotech & Genome (PBE) to Amplify Weight Loss Drug & Treatment ETF (THNR)
PBE

PowerShares Dynamic Biotech & Genome

PBE Description

The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$66.08

Average Daily Volume

5,506

Number of Holdings *

30

* may have additional holdings in another (foreign) market
THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$23.15

Average Daily Volume

2,478

Number of Holdings *

15

* may have additional holdings in another (foreign) market
Performance
Period PBE THNR
30 Days -5.35% -12.44%
60 Days -7.22% -16.42%
90 Days -4.88% -14.44%
12 Months 19.42%
2 Overlapping Holdings
Symbol Grade Weight in PBE Weight in THNR Overlap
AMGN D 4.95% 5.07% 4.95%
OPK A 2.5% 0.21% 0.21%
PBE Overweight 28 Positions Relative to THNR
Symbol Grade Weight
UTHR B 5.84%
ILMN C 5.74%
ALNY D 4.92%
BIIB F 4.23%
NBIX D 4.1%
EXEL B 3.82%
XNCR B 3.74%
MNKD B 3.7%
BMRN F 3.69%
INCY B 3.45%
REGN F 3.43%
TGTX B 3.38%
CPRX C 3.17%
VCYT B 3.09%
ACAD C 3.04%
NTRA B 3.03%
PTGX D 2.97%
BPMC D 2.94%
TECH D 2.9%
VCEL A 2.74%
HALO D 2.62%
RGEN D 2.61%
QGEN D 2.58%
BCRX D 2.56%
COLL F 2.31%
NVAX F 2.17%
CDNA D 2.02%
MYGN F 1.72%
PBE Underweight 13 Positions Relative to THNR
Symbol Grade Weight
LLY F -14.71%
NVO F -13.16%
PFE F -5.03%
TMO D -4.93%
MRK F -4.79%
AZN F -4.62%
WST C -4.49%
TEVA D -3.68%
VKTX F -2.58%
CTLT C -2.0%
HIMS C -0.83%
ALT C -0.27%
TERN F -0.14%
Compare ETFs